Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre van Damme

Showing results (181-190 of 365) with videos related to

Pageof 37
Sort By:
Vaccine|June 12, 2002
Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvantIsabelle Desombere, Marie Van der Wielen, Pierre Van Damme, et al.
Spatial and Spatio-Temporal Epidemiology|November 3, 2020
Can COVID-19 symptoms as reported in a large-scale online survey be used to optimise spatial predictions of COVID-19 incidence risk in Belgium?Thomas Neyens, Christel Faes, Maren Vranckx, et al.
Vaccine|January 23, 2019
Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in BelgiumIne Wouters, Stefanie Desmet, Liesbet Van Heirstraeten, et al.
BMC Infectious Diseases|May 28, 2010
Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative studyPierre Van Damme, Robert Arnou, Froukje Kafeja, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 28, 2005
Immunisation in the current management of cystic fibrosis patientsAnne Malfroot, Georgios Adam, Oana Ciofu, et al.
Vaccine|August 20, 2018
Assessment of the timely administration of the hepatitis B and BCG birth dose and the primary infant vaccination schedule in 2015-2016 in the Mekong Delta, Viet NamTam Thi Pham, Huu Minh Le, Dat Tan Nguyen, et al.
The Pediatric Infectious Disease Journal|December 3, 2009
An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of ageTimo Vesikari, Pierre Van Damme, Niklas Lindblad, et al.
Viral Immunology|April 1, 2011
Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parentsBenson Ogunjimi, Evelien Smits, Niel Hens, et al.
Acta Cardiologica|December 31, 2015
Environmental triggers of acute myocardial infarction: results of a nationwide multiple-factorial population studyMarc J Claeys, Sarah Coenen, Charlotte Colpaert, et al.
BMC Public Health|June 9, 2016
Prevalence of high-risk human papillomavirus and abnormal pap smears in female sex workers compared to the general population in Antwerp, BelgiumAlex Vorsters, Tine Cornelissen, Elke Leuridan, et al.
Pageof 37

Showing results (181-190 of 365) with videos related to

Sort By:
Pageof 37
Vaccine|June 12, 2002
Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvantIsabelle Desombere, Marie Van der Wielen, Pierre Van Damme, et al.
Spatial and Spatio-Temporal Epidemiology|November 3, 2020
Can COVID-19 symptoms as reported in a large-scale online survey be used to optimise spatial predictions of COVID-19 incidence risk in Belgium?Thomas Neyens, Christel Faes, Maren Vranckx, et al.
Vaccine|January 23, 2019
Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in BelgiumIne Wouters, Stefanie Desmet, Liesbet Van Heirstraeten, et al.
BMC Infectious Diseases|May 28, 2010
Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative studyPierre Van Damme, Robert Arnou, Froukje Kafeja, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 28, 2005
Immunisation in the current management of cystic fibrosis patientsAnne Malfroot, Georgios Adam, Oana Ciofu, et al.
Vaccine|August 20, 2018
Assessment of the timely administration of the hepatitis B and BCG birth dose and the primary infant vaccination schedule in 2015-2016 in the Mekong Delta, Viet NamTam Thi Pham, Huu Minh Le, Dat Tan Nguyen, et al.
The Pediatric Infectious Disease Journal|December 3, 2009
An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of ageTimo Vesikari, Pierre Van Damme, Niklas Lindblad, et al.
Viral Immunology|April 1, 2011
Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parentsBenson Ogunjimi, Evelien Smits, Niel Hens, et al.
Acta Cardiologica|December 31, 2015
Environmental triggers of acute myocardial infarction: results of a nationwide multiple-factorial population studyMarc J Claeys, Sarah Coenen, Charlotte Colpaert, et al.
BMC Public Health|June 9, 2016
Prevalence of high-risk human papillomavirus and abnormal pap smears in female sex workers compared to the general population in Antwerp, BelgiumAlex Vorsters, Tine Cornelissen, Elke Leuridan, et al.
Pageof 37